scholarly article | Q13442814 |
P2093 | author name string | Grassi V | |
Tantucci C | |||
Franchini D | |||
Boni E | |||
Corda L | |||
Pini L | |||
Chiroli P | |||
Damiani GP | |||
P2860 | cites work | A simple method to detect expiratory flow limitation during spontaneous breathing | Q72257470 |
Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation | Q72604927 | ||
The effects of beta 2-agonists and caffeine on respiratory and limb muscle performance | Q72655894 | ||
Detection of expiratory flow limitation during mechanical ventilation | Q72785308 | ||
Lung hyperinflation and flow limitation in chronic airway obstruction | Q73161671 | ||
Detection of expiratory flow limitation during exercise in COPD patients | Q73165381 | ||
Quality of life changes in COPD patients treated with salmeterol | Q73227906 | ||
Salmeterol reduces dyspnea and improves lung function in patients with COPD | Q73614794 | ||
STATIC VOLUME-PRESSURE CHARACTERISTICS OF THE RESPIRATORY SYSTEM DURING MAXIMAL EFFORTS | Q76951203 | ||
Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients | Q77561357 | ||
Pulmonary mechanics. A unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjects | Q78842255 | ||
The interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjects | Q78893228 | ||
Psychophysical bases of perceived exertion | Q29615667 | ||
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society | Q29616361 | ||
Breathlessness and exercise in patients with cardiorespiratory disease | Q33472982 | ||
Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects | Q36168525 | ||
Breathlessness in patients with chronic airflow limitation. Mechanisms and management | Q40700701 | ||
Acute bronchodilator trials in chronic obstructive pulmonary disease | Q44654373 | ||
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease | Q46473735 | ||
Predicted values for clinical exercise testing | Q49023950 | ||
Bronchodilator response in chronic obstructive pulmonary disease. | Q50575120 | ||
Partitioning of work of breathing in mechanically ventilated COPD patients. | Q51653641 | ||
The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. | Q52872563 | ||
"Intrinsic" positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease. | Q54335721 | ||
Effects and mechanism of fenoterol on fatigued canine diaphragm | Q69843992 | ||
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease | Q70047755 | ||
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation | Q70210226 | ||
Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect | Q70244445 | ||
Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease | Q70445222 | ||
Pulmonary mechanics during exercise in subjects with chronic airflow obstruction | Q70686088 | ||
Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease | Q71906981 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
P304 | page(s) | 528-532 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | Thorax | Q7796158 |
P1476 | title | Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest | |
P478 | volume | 57 |
Q37236604 | A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma |
Q37808058 | An update on the use of indacaterol in patients with COPD. |
Q51806623 | CPAP and EPAP elicit similar lung deflation in a non-equivalent mode in GOLD 3-4 COPD patients. |
Q35564127 | Clinical dose-response relationship of fluticasone propionate in adults with asthma |
Q80335131 | Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD |
Q55354971 | Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects. |
Q35536935 | Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease |
Q35536743 | Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD |
Q37017336 | Hyperinflation and its management in COPD |
Q35535545 | Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis |
Q36738718 | Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients |
Q37200994 | It's about time--directing our attention toward modifying the course of COPD. |
Q36248482 | Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients |
Q36669434 | Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale |
Q38066983 | New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients |
Q46528034 | The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease |
Q44631821 | Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD. |
Q84272121 | [Pharmacological treatment of hyperinflation] |
Q80447701 | [Which definition to use when defining reversibility of airway obstruction?] |
Search more.